Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.
| dc.contributor.author | Hunsicker, O | |
| dc.contributor.author | Scott, MJ | |
| dc.contributor.author | Miller, TE | |
| dc.contributor.author | Baldini, G | |
| dc.contributor.author | Feldheiser, A | |
| dc.date.accessioned | 2018-07-24T14:40:42Z | |
| dc.date.available | 2018-07-24T14:40:42Z | |
| dc.date.issued | 2015-01 | |
| dc.date.updated | 2018-07-24T14:40:42Z | |
| dc.identifier | S0007-0912(17)30584-6 | |
| dc.identifier.issn | 0007-0912 | |
| dc.identifier.issn | 1471-6771 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | British journal of anaesthesia | |
| dc.relation.isversionof | 10.1093/bja/aeu422 | |
| dc.subject | Humans | |
| dc.subject | Colloids | |
| dc.subject | Isotonic Solutions | |
| dc.subject | Fluid Therapy | |
| dc.subject | Colorectal Surgery | |
| dc.subject | Female | |
| dc.subject | Male | |
| dc.subject | Hydroxyethyl Starch Derivatives | |
| dc.title | Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Miller, TE|0000-0001-8567-6680 | |
| pubs.begin-page | 160 | |
| pubs.end-page | 162 | |
| pubs.issue | 1 | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Anesthesiology, General, Vascular, High Risk Transplant & Critical Care | |
| pubs.organisational-group | Anesthesiology | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.publication-status | Published | |
| pubs.volume | 114 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Hunsicker letter. GI morbitidy as a primary outcome measure. 2015.pdf
- Size:
- 57.49 KB
- Format:
- Adobe Portable Document Format